AR040280A2 - PROCEDURE TO INCREASE YOUR SOLUBILITY IN A WATER MEDIA - Google Patents
PROCEDURE TO INCREASE YOUR SOLUBILITY IN A WATER MEDIAInfo
- Publication number
- AR040280A2 AR040280A2 ARP030102180A ARP030102180A AR040280A2 AR 040280 A2 AR040280 A2 AR 040280A2 AR P030102180 A ARP030102180 A AR P030102180A AR P030102180 A ARP030102180 A AR P030102180A AR 040280 A2 AR040280 A2 AR 040280A2
- Authority
- AR
- Argentina
- Prior art keywords
- solubility
- procedure
- increase
- water media
- sertraline
- Prior art date
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title 1
- VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical compound C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 abstract 2
- 229960002073 sertraline Drugs 0.000 abstract 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
- 239000012736 aqueous medium Substances 0.000 abstract 1
- 239000002609 medium Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Procedimiento para aumentar la solubilidad de la sertralina en un medio de uso acuoso que contiene ion cloruro, que comprende anadir la mencionada sertralina al mencionado medio de uso en una composición de materia que adicionalmente comprende un agente solubilizante.Process for increasing the solubility of sertraline in an aqueous medium containing chloride ion, which comprises adding said sertraline to said medium of use in a composition of matter that additionally comprises a solubilizing agent.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5141397P | 1997-07-01 | 1997-07-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR040280A2 true AR040280A2 (en) | 2005-03-23 |
Family
ID=21971159
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980103146A AR015917A1 (en) | 1997-07-01 | 1998-06-29 | COMPOSITIONS OF MATTER CONTAINING SERTRALIN AND PROCEDURE TO INCREASE YOUR SOLUBILITY IN A WATER MEDIA |
| ARP030102180A AR040280A2 (en) | 1997-07-01 | 2003-06-19 | PROCEDURE TO INCREASE YOUR SOLUBILITY IN A WATER MEDIA |
| ARP030102179A AR040279A2 (en) | 1997-07-01 | 2003-06-19 | COMPOSITIONS CONTAINING SERTRALINE SALT |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980103146A AR015917A1 (en) | 1997-07-01 | 1998-06-29 | COMPOSITIONS OF MATTER CONTAINING SERTRALIN AND PROCEDURE TO INCREASE YOUR SOLUBILITY IN A WATER MEDIA |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP030102179A AR040279A2 (en) | 1997-07-01 | 2003-06-19 | COMPOSITIONS CONTAINING SERTRALINE SALT |
Country Status (34)
| Country | Link |
|---|---|
| EP (1) | EP0999829A1 (en) |
| JP (1) | JP2000514100A (en) |
| KR (1) | KR100366373B1 (en) |
| CN (1) | CN1261794A (en) |
| AP (1) | AP1192A (en) |
| AR (3) | AR015917A1 (en) |
| AU (1) | AU742535B2 (en) |
| BG (1) | BG103918A (en) |
| BR (1) | BR9810739A (en) |
| CA (1) | CA2290974C (en) |
| CO (1) | CO4940495A1 (en) |
| DZ (1) | DZ2548A1 (en) |
| EA (1) | EA002481B1 (en) |
| HN (1) | HN1998000102A (en) |
| HR (1) | HRP980377A2 (en) |
| HU (1) | HUP0002236A3 (en) |
| ID (1) | ID23429A (en) |
| IL (1) | IL133076A (en) |
| IS (1) | IS5260A (en) |
| MA (1) | MA24587A1 (en) |
| NO (1) | NO996520L (en) |
| OA (1) | OA11243A (en) |
| PA (1) | PA8454301A1 (en) |
| PE (1) | PE97199A1 (en) |
| PL (1) | PL337804A1 (en) |
| SK (1) | SK181099A3 (en) |
| TN (1) | TNSN98124A1 (en) |
| TR (1) | TR199903297T2 (en) |
| TW (1) | TW550087B (en) |
| UA (1) | UA67741C2 (en) |
| UY (1) | UY25071A1 (en) |
| WO (1) | WO1999001120A1 (en) |
| YU (1) | YU68299A (en) |
| ZA (1) | ZA985708B (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR200201617T2 (en) | 1999-12-23 | 2002-10-21 | Pfizer Products Inc. | Pharmaceutical compositions that provide enhanced drug concentrations |
| US20030086972A1 (en) * | 2000-08-09 | 2003-05-08 | Appel Leah E. | Hydrogel-driven drug dosage form |
| CA2420535A1 (en) | 2000-08-30 | 2002-03-07 | Mary Tanya Am Ende | Sustained release formulations for growth hormone secretagogues |
| US20040191207A1 (en) * | 2003-03-31 | 2004-09-30 | Lipari John M. | Alpha-hydroxy acid ester drug delivery compositions and methods of use |
| US20100105638A1 (en) * | 2007-03-12 | 2010-04-29 | Kerstin Den-Braven | Cosmetic compositions |
| AU2010285740C1 (en) | 2009-08-19 | 2016-03-17 | Eisai R&D Management Co., Ltd. | Quinoline derivative-containing pharmaceutical composition |
| WO2011081118A1 (en) * | 2009-12-29 | 2011-07-07 | 興和株式会社 | Pharmaceutical composition for oral administration |
| WO2011081117A1 (en) * | 2009-12-29 | 2011-07-07 | 興和株式会社 | Solid pharmaceutical composition for oral administration |
| CN109908354A (en) * | 2017-12-12 | 2019-06-21 | 万特制药(海南)有限公司 | Sertraline hydrochloride takes orally concentrate and its preparation process |
| CN114894736B (en) * | 2022-05-20 | 2025-03-21 | 中化地质矿山总局地质研究院 | A method for determining nitrate in chloride-type brine |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4803076A (en) * | 1986-09-04 | 1989-02-07 | Pfizer Inc. | Controlled release device for an active substance |
| EP0415612B1 (en) * | 1989-08-30 | 1993-11-10 | Pfizer Inc. | Use of sertraline for the treatment of chemical dependencies |
| ZA97976B (en) * | 1996-04-05 | 1997-08-18 | Alza Corp | Uniform drug delivery theraphy. |
-
1998
- 1998-06-15 EA EA199900962A patent/EA002481B1/en unknown
- 1998-06-15 YU YU68299A patent/YU68299A/en unknown
- 1998-06-15 EP EP98923019A patent/EP0999829A1/en not_active Withdrawn
- 1998-06-15 SK SK1810-99A patent/SK181099A3/en unknown
- 1998-06-15 WO PCT/IB1998/000933 patent/WO1999001120A1/en not_active Ceased
- 1998-06-15 PL PL98337804A patent/PL337804A1/en unknown
- 1998-06-15 KR KR10-1999-7011361A patent/KR100366373B1/en not_active Expired - Fee Related
- 1998-06-15 JP JP11506774A patent/JP2000514100A/en active Pending
- 1998-06-15 IL IL13307698A patent/IL133076A/en not_active IP Right Cessation
- 1998-06-15 CN CN98806763A patent/CN1261794A/en active Pending
- 1998-06-15 BR BR9810739-9A patent/BR9810739A/en not_active Application Discontinuation
- 1998-06-15 UA UA99116391A patent/UA67741C2/en unknown
- 1998-06-15 TR TR1999/03297T patent/TR199903297T2/en unknown
- 1998-06-15 HU HU0002236A patent/HUP0002236A3/en unknown
- 1998-06-15 ID IDW991701A patent/ID23429A/en unknown
- 1998-06-15 AU AU75448/98A patent/AU742535B2/en not_active Ceased
- 1998-06-15 CA CA002290974A patent/CA2290974C/en not_active Expired - Fee Related
- 1998-06-25 AP APAP/P/1998/001280A patent/AP1192A/en active
- 1998-06-25 TW TW087110267A patent/TW550087B/en active
- 1998-06-26 PE PE1998000573A patent/PE97199A1/en not_active Application Discontinuation
- 1998-06-29 AR ARP980103146A patent/AR015917A1/en not_active Application Discontinuation
- 1998-06-29 PA PA19988454301A patent/PA8454301A1/en unknown
- 1998-06-29 UY UY25071A patent/UY25071A1/en not_active IP Right Cessation
- 1998-06-30 TN TNTNSN98124A patent/TNSN98124A1/en unknown
- 1998-06-30 MA MA25146A patent/MA24587A1/en unknown
- 1998-06-30 ZA ZA9805708A patent/ZA985708B/en unknown
- 1998-06-30 DZ DZ980158A patent/DZ2548A1/en active
- 1998-07-01 HR HR60/051,413A patent/HRP980377A2/en not_active Application Discontinuation
- 1998-07-01 HN HN1998000102A patent/HN1998000102A/en unknown
- 1998-07-01 CO CO98037137A patent/CO4940495A1/en unknown
-
1999
- 1999-11-19 IS IS5260A patent/IS5260A/en unknown
- 1999-11-23 BG BG103918A patent/BG103918A/en unknown
- 1999-12-21 OA OA9900301A patent/OA11243A/en unknown
- 1999-12-28 NO NO996520A patent/NO996520L/en not_active Application Discontinuation
-
2003
- 2003-06-19 AR ARP030102180A patent/AR040280A2/en unknown
- 2003-06-19 AR ARP030102179A patent/AR040279A2/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9700082A (en) | Composition comprising morphine, polypyrrolidone and a polyalkyleneoxide. | |
| AR000714A1 (en) | A METHOD OF USE OF A CHELING AGENT TO IMPROVE THE COLOR FIDELITY OF WASHED FABRICS AND A COMPOSITION FOR USE IN SUCH METHOD. | |
| ES2095234T3 (en) | METHOD AND FORMULATION USING TYPE II ENDOGLYCOSIDASE. | |
| ES2159111T3 (en) | COMPOSITIONS IN PADS FOR PERSONAL CLEANING, CONTAINING A FRAGRANCE FREE COMPLEX. | |
| BR9806443B1 (en) | process and apparatus to automatically compensate for the volume. | |
| EA199900749A1 (en) | PHARMACEUTICAL COMPOSITION | |
| EP1057862A3 (en) | Polymer film compositions for capsules | |
| BR9703302A (en) | Apparatus and method for the generation and use of iron ions | |
| ES2185936T3 (en) | CLEANING LIQUID COMPOSITIONS CONTAINING RAMIFIED TENSIOACTIVES IN THE HALF OF THE SELECTED CHAIN. | |
| CO4750807A1 (en) | INTERFERON SOLUTION | |
| AR033215A2 (en) | CONCENTRATED HERBICIDE COMPOSITION CONTAINING WATER SOLUTION OF POTASSIUM SALTS AND GLYPHANATE MONOETHANOLAMINE AND A TENSIOACTIVE AGENT | |
| NO984524D0 (en) | Amphipathic molecules such as cholesterol and other lipid uptake inhibitors | |
| AR021777A1 (en) | A COMPOSITION FOR CONDITIONING, CLEARING AND ILLUMINATING THE HAIR AND A METHOD FOR CONDITIONING, CLEARING AND ILLUMINATING THE HAIR. | |
| AR040280A2 (en) | PROCEDURE TO INCREASE YOUR SOLUBILITY IN A WATER MEDIA | |
| HN2001000262A (en) | REPINOTANE KIT | |
| NL1016333A1 (en) | Electron beam writing method, electron beam lithography apparatus, and mask used in the method and apparatus. | |
| ES2151135T3 (en) | PULVERULENT COMPOUND OF HYDROXIPROPIL-BETACICLODEXTRIN AND ITS PREPARATION PROCEDURE. | |
| MX170928B (en) | CLEANING COMPOSITION FOR HARD SURFACES | |
| BR9911464A (en) | Corrosion inhibition methods using isomers of chloro-methylbenzotriazole | |
| AR020695A1 (en) | METHODS TO CONTROL MACROINVERTEBRATES IN WATER SYSTEMS | |
| ES2109632T3 (en) | COMPOSITION OF ANHYDROUS DENTIPHRIC. | |
| AR020703A1 (en) | CLEANING BAR OF HARD SURFACES. | |
| ES2168113T3 (en) | WHITENING DISSOLUTION OF LACTONE / PEROXIDE, WHITENING SYSTEM TO FORM THE SAME AND METHOD OF PREPARATION AND USE OF IT. | |
| DK0943030T3 (en) | Process for reducing sulfur and putty dyes | |
| ES2189150T3 (en) | WATER COATING COMPOSITION. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |